Robert N Correll1, Catherine A Makarewich2, Hongyu Zhang2, Chen Zhang2, Michelle A Sargent1, Allen J York1, Remus M Berretta2, Xiongwen Chen2, Steven R Houser2, Jeffery D Molkentin1,3. 1. Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, 240 Albert Sabin Way, Cincinnati, OH 45229, USA. 2. Department of Physiology, Cardiovascular Research Center, Temple University School of Medicine, 3500 N. Broad Street, Philadelphia, PA 19140, USA. 3. Department of Pediatrics, Howard Hughes Medical Institute, Cincinnati Children's Hospital Medical Center, 240 Albert Sabin Way, Cincinnati, OH 45229-3039, USA.
Abstract
AIMS: L-type Ca2+ channels (LTCCs) in adult cardiomyocytes are localized to t-tubules where they initiate excitation-contraction coupling. Our recent work has shown that a subpopulation of LTCCs found at the surface sarcolemma in caveolae of adult feline cardiomyocytes can also generate a Ca2+ microdomain that activates nuclear factor of activated T-cells signaling and cardiac hypertrophy, although the relevance of this paradigm to hypertrophy regulation in vivo has not been examined. METHODS AND RESULTS: Here we generated heart-specific transgenic mice with a putative caveolae-targeted LTCC activator protein that was ineffective in initiating or enhancing cardiac hypertrophy in vivo. We also generated transgenic mice with cardiac-specific overexpression of a putative caveolae-targeted inhibitor of LTCCs, and while this protein inhibited caveolae-localized LTCCs without effects on global Ca2+ handling, it similarly had no effect on cardiac hypertrophy in vivo. Cardiac hypertrophy was elicited by pressure overload for 2 or 12 weeks or with neurohumoral agonist infusion. Caveolae-specific LTCC activator or inhibitor transgenic mice showed no greater change in nuclear factor of activated T-cells activity after 2 weeks of pressure overload stimulation compared with control mice. CONCLUSION: Our results indicate that LTCCs in the caveolae microdomain do not affect cardiac function and are not necessary for the regulation of hypertrophic signaling in the adult mouse heart. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: L-type Ca2+ channels (LTCCs) in adult cardiomyocytes are localized to t-tubules where they initiate excitation-contraction coupling. Our recent work has shown that a subpopulation of LTCCs found at the surface sarcolemma in caveolae of adult feline cardiomyocytes can also generate a Ca2+ microdomain that activates nuclear factor of activated T-cells signaling and cardiac hypertrophy, although the relevance of this paradigm to hypertrophy regulation in vivo has not been examined. METHODS AND RESULTS: Here we generated heart-specific transgenic mice with a putative caveolae-targeted LTCC activator protein that was ineffective in initiating or enhancing cardiac hypertrophy in vivo. We also generated transgenic mice with cardiac-specific overexpression of a putative caveolae-targeted inhibitor of LTCCs, and while this protein inhibited caveolae-localized LTCCs without effects on global Ca2+ handling, it similarly had no effect on cardiac hypertrophy in vivo. Cardiac hypertrophy was elicited by pressure overload for 2 or 12 weeks or with neurohumoral agonist infusion. Caveolae-specific LTCC activator or inhibitor transgenic mice showed no greater change in nuclear factor of activated T-cells activity after 2 weeks of pressure overload stimulation compared with control mice. CONCLUSION: Our results indicate that LTCCs in the caveolae microdomain do not affect cardiac function and are not necessary for the regulation of hypertrophic signaling in the adult mouse heart. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Catherine A Makarewich; Robert N Correll; Hui Gao; Hongyu Zhang; Baohua Yang; Remus M Berretta; Victor Rizzo; Jeffery D Molkentin; Steven R Houser Journal: Circ Res Date: 2012-02-02 Impact factor: 17.367
Authors: David M Harris; Geoffrey D Mills; Xiongwen Chen; Hajime Kubo; Remus M Berretta; V Scott Votaw; Luis F Santana; Steven R Houser Journal: Circ Res Date: 2005-02-10 Impact factor: 17.367
Authors: Robert N Correll; Chunyan Pang; Brian S Finlin; Alexandria M Dailey; Jonathan Satin; Douglas A Andres Journal: J Biol Chem Date: 2007-08-07 Impact factor: 5.157
Authors: Catherine A Makarewich; Hongyu Zhang; Jennifer Davis; Robert N Correll; Danielle M Trappanese; Nicholas E Hoffman; Constantine D Troupes; Remus M Berretta; Hajime Kubo; Muniswamy Madesh; Xiongwen Chen; Erhe Gao; Jeffery D Molkentin; Steven R Houser Journal: Circ Res Date: 2014-07-21 Impact factor: 17.367
Authors: Koichiro Kuwahara; Yanggan Wang; John McAnally; James A Richardson; Rhonda Bassel-Duby; Joseph A Hill; Eric N Olson Journal: J Clin Invest Date: 2006-11-09 Impact factor: 14.808
Authors: Xiongwen Chen; Rachel M Wilson; Hajime Kubo; Remus M Berretta; David M Harris; Xiaoying Zhang; Naser Jaleel; Scott M MacDonnell; Claudia Bearzi; Jochen Tillmanns; Irina Trofimova; Toru Hosoda; Federico Mosna; Leanne Cribbs; Annarosa Leri; Jan Kajstura; Piero Anversa; Steven R Houser Journal: Circ Res Date: 2007-02-01 Impact factor: 17.367
Authors: Brooke M Ahern; Bryana M Levitan; Sudhakar Veeranki; Mihir Shah; Nemat Ali; Andrea Sebastian; Wen Su; Ming C Gong; Jiayang Li; Julian E Stelzer; Douglas A Andres; Jonathan Satin Journal: J Biol Chem Date: 2019-05-30 Impact factor: 5.157
Authors: Cherrie H T Kong; Simon M Bryant; Judy J Watson; Hanne C Gadeberg; David M Roth; Hemal H Patel; Mark B Cannell; Clive H Orchard; Andrew F James Journal: J Gerontol A Biol Sci Med Sci Date: 2018-05-09 Impact factor: 6.053
Authors: Jake Russell; Eugene F Du Toit; Jason N Peart; Hemal H Patel; John P Headrick Journal: Cardiovasc Diabetol Date: 2017-12-04 Impact factor: 9.951
Authors: Javier Duran; Mayarling Francisca Troncoso; Daniel Lagos; Sebastian Ramos; Gabriel Marin; Manuel Estrada Journal: Int J Mol Sci Date: 2018-05-18 Impact factor: 5.923